A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer
Musende, Alain Gulenga, Eberding, Andy, Wood, Catherine A, Adomat, Hans, Fazli, Ladan, Hurtado-Coll, Antonio, Jia, William, Bally, Marcel B, Tomlinson Guns, Emma S
Published in Anti-cancer drugs (01.06.2012)
Published in Anti-cancer drugs (01.06.2012)
Get more information
Journal Article